Clinical trial
Desmopressin as a Therapy for Nocturnal Enuresis in Pediatric Patients With Sickle Cell Disease
NCT04420585 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Desmopressin as a Therapy for Nocturnal Enuresis in Pediatric Patients With Sickle Cell Disease
- Lead sponsor
- Montefiore Medical Center
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 7, 2020
- Completion date
- June 12, 2023
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.